Genprex, Inc. — Investor Relations & Filings
Filings indexed
465
across all filing types
Latest filing
2026-04-30
Regulatory Filings
Country
US
United States of America
Listing
US
GNPX
Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapeutic options for large patient populations. Its oncology pipeline includes clinical-stage programs for lung cancer, such as the Acclaim-3 trial in small cell lung cancer (SCLC) and other programs for non-small cell lung cancer (NSCLC). In addition to its cancer programs, Genprex is developing gene therapies for diabetes. The company utilizes a proprietary, non-viral nanoparticle delivery system to systemically deliver therapeutic genes.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Genprex, Inc. (0001595248) (Filer) | 2026-04-30 | English | |
| 8-K - Genprex, Inc. (0001595248) (Filer) | 2026-04-28 | English | |
| 8-K - Genprex, Inc. (0001595248) (Filer) | 2026-04-21 | English | |
| 4 - GENPREX, INC. (0001595248) (Filer) | 2026-02-27 | English | |
| 4 - GENPREX, INC. (0001595248) (Filer) | 2026-02-27 | English | |
| 8-K - Genprex, Inc. (0001595248) (Filer) | 2026-02-23 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
12 filings
| |||||
| 39079012 | 8-K - Genprex, Inc. (0001595248) (Filer) | 2026-04-30 | English | ||
| 37966942 | 8-K - Genprex, Inc. (0001595248) (Filer) | 2026-04-28 | English | ||
| 34744649 | 8-K - Genprex, Inc. (0001595248) (Filer) | 2026-04-21 | English | ||
| 32894757 | 4 - GENPREX, INC. (0001595248) (Filer) | 2026-02-27 | English | ||
| 32894758 | 4 - GENPREX, INC. (0001595248) (Filer) | 2026-02-27 | English | ||
| 32827314 | 8-K - Genprex, Inc. (0001595248) (Filer) | 2026-02-23 | English | ||
| 30796874 | SCHEDULE 13G Filing | 2026-02-11 | English | ||
| 19423450 | 8-K - Genprex, Inc. (0001595248) (Filer) | 2026-02-10 | English | ||
| 12735587 | FORM 8-K | 2026-01-09 | English | ||
| 12735588 | FORM S-8 | 2026-01-09 | English | ||
| 12735590 | FORM 8-K | 2026-01-07 | English | ||
| 12735589 | FORM 8-K | 2026-01-06 | English | ||
|
2025
3 filings
| |||||
| 12735591 | FORM 4 | 2025-12-23 | English | ||
| 12735592 | FORM 4 | 2025-12-23 | English | ||
| 12735593 | FORM 4 | 2025-12-23 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
DG INNOVATE PLC
Develops sustainable technologies for electric mobility and…
|
DGI | GB | Professional, scientific and te… |
|
Dianthus Therapeutics, Inc. /DE/
Clinical-stage biotech developing therapies for severe auto…
|
DNTH | US | Professional, scientific and te… |
|
DIMERIX LIMITED
Develops GPCR-targeted therapies for inflammatory kidney an…
|
DXB | AU | Professional, scientific and te… |
|
Dogwood Therapeutics, Inc.
A biotech company developing novel therapeutics for pain an…
|
DWTX | US | Professional, scientific and te… |
|
DORSAVI LTD
Develops clinical-grade wearable sensors and software for h…
|
DVL | AU | Professional, scientific and te… |
|
DreamCIS INC.
Contract research organization for pharma, biotech, and med…
|
223250 | KR | Professional, scientific and te… |
|
DT&CRO CO., Ltd.
A full-service CRO providing non-clinical and clinical stud…
|
383930 | KR | Professional, scientific and te… |
|
Dundee Sustainable Technologies Inc.
Develops proprietary, sustainable metallurgical processes f…
|
DST | CA | Professional, scientific and te… |
|
D.Western Therapeutics Institute, Inc.
Biotechnology firm developing drugs from a proprietary prot…
|
4576 | JP | Professional, scientific and te… |
|
Ecopia BioSciences Inc.
Developing novel anticancer agents and therapeutic solution…
|
EIA | CA | Professional, scientific and te… |
Genprex, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35333/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35333 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35333 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35333 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35333}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Genprex, Inc. (id: 35333)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.